$CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Stock
$celz
2018 Q3 Form 10-Q Financial Statement
#000114420418044664 Filed on August 14, 2018
Income Statement
Concept | 2018 Q3 | 2018 Q2 | 2017 Q2 |
---|---|---|---|
Revenue | $52.40K | $4.800K | $0.00 |
YoY Change | |||
Cost Of Revenue | $36.40K | $2.528K | $0.00 |
YoY Change | |||
Gross Profit | $16.01K | $2.272K | $0.00 |
YoY Change | |||
Gross Profit Margin | 30.54% | 47.33% | |
Selling, General & Admin | $280.0K | $310.0K | $370.0K |
YoY Change | 40.0% | -16.22% | 94.74% |
% of Gross Profit | 1749.45% | 13644.37% | |
Research & Development | $2.884K | $4.200K | $25.19K |
YoY Change | -96.71% | -83.33% | 39.72% |
% of Gross Profit | 18.02% | 184.86% | |
Depreciation & Amortization | $10.00K | $0.00 | $10.00K |
YoY Change | -100.0% | ||
% of Gross Profit | 62.48% | 0.0% | |
Operating Expenses | $290.8K | $317.1K | $396.0K |
YoY Change | -1.41% | -19.92% | 90.29% |
Operating Profit | -$274.8K | -$314.8K | -$396.0K |
YoY Change | -6.84% | -20.5% | 89.25% |
Interest Expense | $377.0K | $413.0K | $63.24K |
YoY Change | 190.53% | 553.06% | 5399.13% |
% of Operating Profit | |||
Other Income/Expense, Net | -$1.296M | -$6.118M | -$490.4K |
YoY Change | -633.81% | 1147.56% | 42540.43% |
Pretax Income | -$1.571M | -$6.432M | -$886.4K |
YoY Change | 2910.66% | 625.71% | 322.07% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$1.571M | -$6.432M | -$886.4K |
YoY Change | 2910.66% | 625.71% | 323.59% |
Net Earnings / Revenue | -2998.13% | -134008.42% | |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$1.593K | -$7.728K | -$6.255K |
COMMON SHARES | |||
Basic Shares Outstanding | 717.1M shares | 106.3M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2018 Q3 | 2018 Q2 | 2017 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $170.0K | $100.0K | $100.0K |
YoY Change | 750.0% | 0.0% | 233.33% |
Cash & Equivalents | $172.8K | $100.5K | $104.4K |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | $14.00K | $4.800K | |
Other Receivables | $0.00 | $0.00 | |
Total Short-Term Assets | $186.8K | $105.3K | $100.0K |
YoY Change | 780.62% | 5.3% | 233.33% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $168.8K | $174.1K | $199.6K |
YoY Change | -10.59% | -12.79% | 117.73% |
TOTAL ASSETS | |||
Total Short-Term Assets | $186.8K | $105.3K | $100.0K |
Total Long-Term Assets | $168.8K | $174.1K | $199.6K |
Total Assets | $355.6K | $279.4K | $299.6K |
YoY Change | 69.34% | -6.75% | 146.23% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $242.8K | $272.8K | $53.20K |
YoY Change | 51.78% | 412.8% | 107.8% |
Accrued Expenses | $29.64K | $40.06K | $9.869K |
YoY Change | 196.4% | 305.87% | 260.71% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $130.0K | $130.0K | $270.0K |
YoY Change | -48.0% | -51.85% | 285.71% |
Long-Term Debt Due | $210.0K | $240.0K | |
YoY Change | 61.54% | ||
Total Short-Term Liabilities | $7.710M | $10.87M | $1.314M |
YoY Change | 507.05% | 727.41% | 332.17% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $10.00K |
YoY Change | -100.0% | -100.0% | -85.71% |
Other Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $10.00K |
YoY Change | -100.0% | -100.0% | -85.71% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $7.710M | $10.87M | $1.314M |
Total Long-Term Liabilities | $0.00 | $0.00 | $10.00K |
Total Liabilities | $7.710M | $10.87M | $1.322M |
YoY Change | 502.31% | 722.23% | 254.42% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$19.02M | -$17.44M | -$1.896M |
YoY Change | 819.94% | 430.29% | |
Common Stock | $11.66M | $6.850M | $873.7K |
YoY Change | 683.97% | 722.57% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$7.354M | -$10.59M | -$1.020M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $355.6K | $279.4K | $299.6K |
YoY Change | 69.34% | -6.75% | 146.23% |
Cashflow Statement
Concept | 2018 Q3 | 2018 Q2 | 2017 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.571M | -$6.432M | -$886.4K |
YoY Change | 2910.66% | 625.71% | 323.59% |
Depreciation, Depletion And Amortization | $10.00K | $0.00 | $10.00K |
YoY Change | -100.0% | ||
Cash From Operating Activities | -$350.0K | -$250.0K | -$270.0K |
YoY Change | 25.0% | -7.41% | 170.0% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $100.0K | |
YoY Change | -100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | -$100.0K | |
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 420.0K | 250.0K | 380.0K |
YoY Change | 366.67% | -34.21% | 245.45% |
NET CHANGE | |||
Cash From Operating Activities | -350.0K | -250.0K | -270.0K |
Cash From Investing Activities | 0.000 | -100.0K | |
Cash From Financing Activities | 420.0K | 250.0K | 380.0K |
Net Change In Cash | 70.00K | 0.00000000008731 | 10.00K |
YoY Change | -177.78% | -100.0% | 0.0% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$350.0K | -$250.0K | -$270.0K |
Capital Expenditures | $0.00 | $100.0K | |
Free Cash Flow | -$250.0K | -$370.0K | |
YoY Change | -32.43% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: "times new roman", times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div> – The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
us-gaap |
Revenues
Revenues
|
14400 | USD | |
us-gaap |
Revenues
Revenues
|
0 | USD | |
CY2018Q2 | us-gaap |
Revenues
Revenues
|
4800 | USD |
CY2017Q2 | us-gaap |
Revenues
Revenues
|
0 | USD |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1877 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
142423 | USD | |
CY2018Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
0 | USD |
CY2017Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
140957 | USD |
CY2018Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
118434 | USD |
CY2018Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
554658 | USD |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
4928 | USD | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD | |
CY2018Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2528 | USD |
CY2017Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
0 | USD |
us-gaap |
Gross Profit
GrossProfit
|
9472 | USD | |
us-gaap |
Gross Profit
GrossProfit
|
0 | USD | |
CY2018Q2 | us-gaap |
Gross Profit
GrossProfit
|
2272 | USD |
CY2017Q2 | us-gaap |
Gross Profit
GrossProfit
|
0 | USD |
dei |
Document Type
DocumentType
|
10-Q | ||
CY2018Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
673092 | USD |
CY2018Q2 | us-gaap |
Cash
Cash
|
100501 | USD |
CY2017Q4 | us-gaap |
Cash
Cash
|
13697 | USD |
CY2018Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4800 | USD |
CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
4801 | USD |
dei |
Amendment Flag
AmendmentFlag
|
false | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-1129707 | USD | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
|
2512357 | USD | |
CY2018Q2 | us-gaap |
Assets
Assets
|
279378 | USD |
CY2017Q4 | us-gaap |
Assets
Assets
|
203147 | USD |
CY2018Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
7000000 | shares |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7400 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
85020 | USD | |
CY2018Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4200 | USD |
CY2017Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
25189 | USD |
dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-06-30 | ||
CY2018Q2 | us-gaap |
Assets Current
AssetsCurrent
|
105301 | USD |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
18498 | USD |
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
510546 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
546394 | USD | |
CY2018Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
307616 | USD |
CY2017Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
368016 | USD |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
10572 | USD | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
5423 | USD | |
CY2018Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
5286 | USD |
CY2017Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2786 | USD |
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
CY2018Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2018Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
174077 | USD |
CY2017Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
184649 | USD |
CY2017Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
1309190 | USD |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
dei |
Entity Registrant Name
EntityRegistrantName
|
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
549495 | USD | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
55941 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
528518 | USD | |
us-gaap |
Operating Expenses
OperatingExpenses
|
636837 | USD | |
CY2018Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
317102 | USD |
CY2017Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
395991 | USD |
CY2018Q2 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
3271870 | USD |
CY2018Q2 | us-gaap |
Management Fee Payable
ManagementFeePayable
|
254050 | USD |
CY2018Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
-4822943 | USD | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
10930166 | USD | |
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2017Q4 | us-gaap |
Management Fee Payable
ManagementFeePayable
|
352750 | USD |
CY2018Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
239980 | USD |
us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
502000 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-519046 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-636837 | USD | |
CY2018Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-314830 | USD |
CY2017Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-395991 | USD |
celz |
Increase In Principal Balance Due To Penalty Provision
IncreaseInPrincipalBalanceDueToPenaltyProvision
|
12500 | USD | |
celz |
Increase In Principal Balance Due To Penalty Provision
IncreaseInPrincipalBalanceDueToPenaltyProvision
|
0 | USD | |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001187953 | ||
us-gaap |
Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
|
-13392280 | USD | |
us-gaap |
Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
|
-427125 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
604303 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
65745 | USD | |
CY2018Q2 | us-gaap |
Interest Expense
InterestExpense
|
412995 | USD |
CY2017Q2 | us-gaap |
Interest Expense
InterestExpense
|
63240 | USD |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
496645 | USD | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | USD | |
dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | ||
CY2018Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2018Q2 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
9928770 | USD |
CY2018Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
272831 | USD |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
237566 | USD |
CY2018Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
40055 | USD |
CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
23140 | USD |
CY2018Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
dei |
Trading Symbol
TradingSymbol
|
CELZ | ||
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
496645 | USD | |
CY2018Q2 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
650929 | USD |
CY2017Q2 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | USD |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
13392280 | USD | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
427125 | USD | |
CY2018Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
6355508 | USD |
CY2017Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
427125 | USD |
CY2018Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
717148155 | shares |
CY2018Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
3000000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
600000000 | shares |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
0 | USD | |
CY2017Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
251748 | USD |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
35265 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-13181 | USD | |
CY2018Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
677730755 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
115399226 | shares |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-13499938 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-492870 | USD | |
CY2018Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-6117574 | USD |
CY2017Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-490365 | USD |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0263 | pure | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-14018984 | USD | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1129707 | USD | |
CY2018Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-6432404 | USD |
CY2017Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-886356 | USD |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
52637 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
5754 | USD | |
CY2018Q2 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
125000 | USD |
CY2017Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
125000 | USD |
CY2018Q2 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
0 | USD |
CY2017Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
125000 | USD |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
51300 | USD | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
13000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14018984 | USD | |
CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6432404 | USD |
CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-886356 | USD |
us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
93000000 | shares | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | ||
CY2018Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
CY2017Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-409702 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-493222 | USD | |
CY2018Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
10800 | USD |
CY2017Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
10800 | USD |
CY2018Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
9928770 | USD |
CY2017Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
1309190 | USD |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
407236924 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
105667617 | shares | |
CY2018Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
623924281 | shares |
CY2017Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
106226387 | shares |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
0 | USD | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
100000 | USD | |
CY2018Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10871486 | USD |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2435194 | USD |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-100000 | USD | |
CY2018Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
0 | USD |
CY2017Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
915 | USD |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | USD | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
90000 | USD | |
us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
189800 | USD | |
us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | USD | |
CY2018Q2 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
0 | USD |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
3211 | USD |
CY2018Q2 | us-gaap |
Liabilities
Liabilities
|
10871486 | USD |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
2439320 | USD |
celz |
Prepayment Premium Paid On Convertible Debt
PrepaymentPremiumPaidOnConvertibleDebt
|
57004 | USD | |
celz |
Prepayment Premium Paid On Convertible Debt
PrepaymentPremiumPaidOnConvertibleDebt
|
0 | USD | |
CY2018Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2018Q2 | celz |
Working Capital Deficit
WorkingCapitalDeficit
|
10766185 | USD |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
743310 | USD | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
285750 | USD | |
CY2018Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2018Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-17444664 | USD |
CY2017Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
92775038 | shares | |
CY2018Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
677133 | USD |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
114800 | USD |
CY2018Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
6172423 | USD |
CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1074707 | USD |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
86804 | USD | |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-117472 | USD | |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
13697 | USD |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
221868 | USD |
us-gaap |
Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
|
From March 2017 through May 2018, the Company issued 78,526,087 warrants to multiple parties associated with the issuance of convertible notes. The issued warrants expire 5 years from the date of issuance and have anti-dilution and re-pricing features. | ||
CY2018Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
677130755 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
114799226 | shares |
celz |
Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
|
0 | USD | |
celz |
Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
|
100000 | USD | |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3425680 | USD |
CY2018Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
100501 | USD |
CY2017Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
104396 | USD |
CY2018Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
279378 | USD |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
203147 | USD |
celz |
Reimbursement Of Management Fees
ReimbursementOfManagementFees
|
35000 | USD | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
6670 | USD | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
4050 | USD | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD | |
celz |
Fair Value Of Warrants Issued In Private Placement
FairValueOfWarrantsIssuedInPrivatePlacement
|
0 | USD | |
celz |
Fair Value Of Warrants Issued In Private Placement
FairValueOfWarrantsIssuedInPrivatePlacement
|
5546 | USD | |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
5511172 | USD | |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD | |
CY2017Q2 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
50000 | USD |
CY2017Q4 | celz |
Management Reimbursement Agreement Description
ManagementReimbursementAgreementDescription
|
At the option of CMH, the reimbursable amounts set forth in the Agreement may be paid from time to time in shares of common stock of the Company at a price equal to a 30% discount to the lowest closing price during the 20 trading days prior to time the notice is given. The Agreement may be terminated by either party upon 30 days’ prior written notice. | |
CY2018Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
54200 | USD |
CY2018Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
4000 | USD |
CY2018Q1 | us-gaap |
Legal Fees
LegalFees
|
2000 | USD |
celz |
Warrant Term
WarrantTerm
|
P5Y | ||
CY2017Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
23426087 | shares |
celz |
Class Of Warrant Issued
ClassOfWarrantIssued
|
66176923 | shares | |
celz |
Warrant Exercises
WarrantExercises
|
-156560322 | shares | |
celz |
Warrant Antidilution And Modification
WarrantAntidilutionAndModification
|
159727241 | shares | |
celz |
Warrant Forfeitures Or Cancellations
WarrantForfeituresOrCancellations
|
-15200000 | shares | |
CY2018Q2 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
77569929 | shares |
CY2018Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.0038 | |
CY2018Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-10592108 | USD |
CY2017Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-2236173 | USD |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
496506 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
475750 | USD | |
us-gaap |
Stock Issued1
StockIssued1
|
150000 | USD | |
us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |